EMA: Q&As on the Topic of "Parallel Distribution" updated

Recommendation
21 October 2025
Barcelona, Spain
An ECA Course prior to the 28th APIC/CEFIC Global GMP & Regulatory API Conference
Again, the "Frequently asked questions about parallel distribution" were revised and published on the EMA website. The information provided by the EMA on parallel distribution of centrally authorised medicinal products is set out in the Q&A in six paragraphs:
- General
- Initial notification
- Parallel distribution notification check
- Post - Parallel distribution notice guidance
- Safety updates/bulk changes/annual update
- Fees
In the latest version, the following question has been added to the first section "General":
- 07. What to do when my organisation details have changed?
In the fifth paragraph "Safety updates/bulk changes/annual update", questions 4 and 5 and their answers have been updated:
- 04. How to submit a bulk change?
- 05. What is an annual update?
The four other sections remain unchanged.
The updates and the complete list of answers to the "Frequently asked questions about parallel distribution" can be found on the EMA website.
Related GMP News
01.10.2025Updated Classification Guideline Published
16.09.2025EMA updates IRIS Documents
16.09.2025eSubmission: Update to the 'PLM Portal eAF - Release Notes'
16.09.2025Centralised Procedures: Updated Q&As
06.08.2025WHO: TRS 1060 regulatory Guidelines published
30.07.2025Swissmedic/EMA: M4Q(R2) Guideline published for Comment